Date | Revenue Per Share | Dividend Per Share | Free Cash Flow Per Share | Return on Assets (ROA) |
---|
CEO | Mr. Andrew Gideon Hall CA (SA), BPharm |
IPO Date | March 6, 2000 |
Location | South Africa |
Headquarters | 1 New Road |
Employees | 2,549 |
Sector | Health Care |
Industries |
Adcock Ingram Holdings Limited manufactures, markets, and distributes healthcare products in South Africa, the United States, Canada, the United Kingdom, rest of Europe, and internationally. It offers a portfolio of over the counter products, prescription medicines, and consumer products, as well as instrumentation and surgical products. The company also provides pharmaceutical products in a range of therapeutic classes, such as women's health, cannabidiol, antiretroviral, dermatology, central nervous system, respiratory, ophthalmology, generics, cardiovascular, pain, gastroenterology, energy supplements, colds and flu, personal care, feminine hygiene, digestive well-being, allergies, baby care, cough, food and nutrition supplements, vitamins, and minerals supplements. In addition, it manufactures and supplies hospital and critical care products, including intravenous solutions, renal dialysis systems, and blood collection products. The company serves private and public sectors. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa.
Past 5 years
USD 19.41
USD 0.80
USD 15.24
USD 8.67
USD 5.14
StockViz Staff
January 15, 2025
Any question? Send us an email